Sociedad Americana de Hirudoterapia

Medicinal leech therapy in pain syndromes: a narrative review

Koeppen D, Aurich M, Rampp T (2013) · Wiener Medizinische Wochenschrift · n=0

Detalle de evidencia de RCTReferencia del ensayo
GRADE muy bajaEvidencia insuficienteCondición: Knee Osteoarthritis →

Perfil del estudio

Diseño
narrative review of medicinal leech therapy efficacy across pain-relevant clinical conditions (Biebertaler Blutegelzucht GmbH, Germany)
Tamaño de la muestra (n)
Intervención
Synthesis of published clinical studies and case reports of medicinal leech therapy in pain syndromes - osteoarthritis, lateral epicondylitis, thrombophlebitis, varicose veins, edema, hematoma, and other indications
Comparador
No quantitative comparator - narrative synthesis only
Punto final primario
Qualitative assessment of leech therapy analgesic effects across pain syndromes
Resultado primario
Narrative consolidation: pain relief from leech therapy is described as rapid, effective, and long-lasting across multiple chronic-pain indications; mode of action attributed to anti-inflammatory, thrombolytic, anti-coagulant, and blood/lymph circulation-enhancing properties of leech saliva; specific analgesic substance not yet identified
Duración del seguimiento
not applicable (narrative review)

Hallazgos clave

  • Comprehensive narrative review of leech therapy in pain syndromes by the principal European medical leech supplier (Biebertaler Blutegelzucht)
  • Synthesizes evidence across osteoarthritis, lateral epicondylitis, thrombophlebitis, varicose veins, edema, and hematoma
  • Concludes that leech-mediated analgesia is rapid, effective, and long-lasting in many conditions
  • Mechanistic discussion emphasizes anti-inflammatory, thrombolytic, anti-coagulant, and circulation-enhancing properties
  • Notes that the specific analgesic compound in leech saliva remains unidentified - hypothesis-generating

Limitaciones

  • Narrative review only - no formal systematic search or quality assessment
  • Author affiliation with leech-supplier company creates COI concern
  • Includes case reports and uncontrolled studies alongside RCTs without weighting
  • No GRADE rating provided
  • Not a primary source of evidence - useful as context but not as outcome evidence

Implicaciones clínicas

Koeppen 2013 is the most-cited narrative review of leech therapy in pain syndromes and is widely referenced in European integrative-medicine practice. It is most useful to clinicians as a contextual overview rather than a primary evidence source. The author's affiliation with the principal European leech supplier (Biebertaler Blutegelzucht) should be disclosed to readers but does not invalidate the underlying citations. For ASH editorial purposes, this review is cited only as a mechanism-and-overview reference; quantitative effect estimates should come from underlying RCTs (Michalsen 2003, Andereya 2008, Stange 2011/2012, Lauche 2014 meta-analysis).

Estudios relacionados

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.